Media Releases 2004 8 December 2004
Prana Raises US$3.7 Million Through Exercise of 8.6 Million Options 17 November 2004
Prana Announces Results of Annual General Meeting to Shareholders 8 November 2004
Prana to Present at CIBC World Markets 19th Annual Healthcare Conference 19 October 2004
Prana to Present at Rodman & Renshaw 6th Annual Healthcare Conference 18 October 2004
Prana Plans to Initiate Phase II/III Alzheimer's Disese Study 18 October 2004
Prana to Hold Analyst Day October 18 15 October 2004
Journal of Biological Chemistry Paper Further Validates Prana Science 12 October 2004
Prana's Open Label Extension Study of PBT-1 Reinforces Positive Phase II Results 6 October 2004
Co-Founding Scientist Awarded 2004 Zenith Fellow Award for Alzheimer's Research 9 August 2004
Amendment to Prana Settles Clioquinol Patent Litigation 9 August 2004
Prana Settles Clioquinol Patent Litigation 9 August 2004
Prana Added to Forbes Neurological Drug Watch List 6 August 2004
Prana Appoints U.S. Based CEO 27 July 2004
Prana to Present at Banc of America Specialty Pharmaceuticals Conference:
New Products, New Paradigms 19 July 2004
Prana Presents at the 9th International Conference on Alzheimer's Disease 23 June 2004
Prana's Senior Scientific Consultant to Take Up Federation Fellowship in Melbourne 17 June 2004
Prana's Scientists on Australian ABC TV Science Program, Catalyst 20 May 2004
Webcast Available For Prana's Presentation at Banc of America 2004 Healthcare Conference 13 May 2004
Prana's Founding Scientist to Present at Banc of America 2004 Healthcare Conference 12 May 2004
Prana at the Rodman & Renshaw Techvest Global Healthcare Conference 28 April 2004
US Health Funds Invest USD 20 Million in Prana Biotechnology 16 April 2004
Prana's Alzheimer's Drug Shows Continued romise in Extended Clinical Trial 12 April 2004
Wall Street Journal Article Profiles Challenges for Alternative Alzheimer's Researchers 7 April 2004
Journal of Neuroscience Paper Further Validates Prana Science 26 March 2004
Prana Appoints Leading US Sector Analyst to Board 26 March 2004
Prana Added to Forbes Neurological Drug Watch List 25 February 2004
Dr Ashley Bush Signs 10 Year Consultancy Agreement With Prana 18 February 2004
Australian Government Supports Prana's Drug, PBT-2 With $1.35 million Start Grant
|
